{"title": "PDF", "author": "PDF", "url": "https://www.scielo.org.mx/pdf/cms/v33n3/2954-3835-cms-33-03-118.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "La una condici\u00f3n inflamatoria multifactorial del miocardio. La miocarditis ha sido reconocida reciente - mente como un evento adverso, en pacientes vacunados con - tra COVID-19 con Pfizer-BioNTech y Moderna (vacunas de ARNm), principalmente en adolescentes y adultos j\u00f3venes. La resonancia magn\u00e9tica cardiaca (RMC) permite caracterizar el tejido mioc\u00e1rdico y la funci\u00f3n cardiaca y se ha convertido en el est\u00e1ndar de oro no-invasivo en pacientes con sospecha de miocarditis aguda. Los autores presentan a un paciente masculino de 16 a\u00f1os con dolor tor\u00e1cico punzante tras la segunda dosis de inmunizaci\u00f3n contra el SARS-CoV-2 con la vacuna BNT162B2 (Pfizer-BioNTech). El electrocardiograma (ECG) mostr\u00f3 elevaci\u00f3n del segmento ST y aumento de los biomarcadores de lesi\u00f3n mioc\u00e1rdica. La angiotomograf\u00eda (AngioTC) mostr\u00f3 signos sutiles de hipoperfusi\u00f3n mioc\u00e1r - dica y disfunci\u00f3n ventricular izquierda. Se realiz\u00f3 RMC con gadolinio, identificando hipocinesia global del ventr\u00edculo izquierdo (VI), hiperemia por edema mioc\u00e1rdico y realce tard\u00edo de gadolinio (RTG) como evidencia de lesi\u00f3n mioc\u00e1r - dica y marcadores de lesi\u00f3n inflamatoria intramioc\u00e1rdica no-isqu\u00e9mica. Habiendo excluido otras etiolog\u00edas, se propone que esta presentaci\u00f3n de miocarditis aguda sea una reacci\u00f3n adversa asociada a la vacuna BNT162b2 contra COVID-19. Los riesgos a largo plazo de la vacuna contra la COVID-19 en ni\u00f1os, adolescentes y adultos j\u00f3venes a\u00fan se desconocen, por lo que ser\u00e1 necesario seguir investigando.ABSTRACT Myocarditis is a multifactorial pain after the of immunization be an adverse reaction associated with the BNT162b2 vaccine against COVID-19. The long-term risks of the COVID-19 vaccine in children, adolescents and young adults are still unknown, and after against COVID-19 in an adolescent patient Miocarditis aguda tras la administraci\u00f3n de la vacuna BNT162b2 (Pfizer-BioNTech) contra COVID-19 en un paciente adolescente Samuel Christus Monterrey, Nuevo Le\u00f3n, M\u00e9xico. Cardiovascular imaging cardiologist. Christus Muguerza Hospital Alta Especialidad, Monterrey, Nuevo Le\u00f3n, M\u00e9xico. \u00a7 Medical internship. Christus Muguerza Hospital Alta Especialidad, Monterrey, Nuevo Le\u00f3n, M\u00e9xico.Clinical case Vol. 33 No. 3 July-September 2022Cardiovascular and M Science119 L\u00f3pez-Mart\u00ednez SI immunological and immunohistochemical criteria. The World Health Organization and the working group of the Society and International Federation of Cardiology on the definition and classification of cardiomyopathies histologically define myocarditis as the presence of inflammatory infiltrates in the myocardium with degeneration and necrosis criteria). Regarding immunohistochemical criteria the diagnosis would be made in the presence in the myocardium of 14 leukocytes/mm 2, including up to 4 monocytes/mm2 and 7 eliminate the causal agent accompanied by edema, necrosis and regional or global alterations of myocardial contractility. Complete recovery of tissue and function can be seen in uncomplicated cases, whereas in severe cases an autoimmune reaction is triggered in the heart with myocardial necrosis and the release of antigens that perpetuate the viruses are echovirus, influenza, Epstein-Barr, parvovirus B19 and herpes virus. In the past few years, myocarditis has been recognized as a complication of severe COVID-19. 2,4-6 With the emerging use of the vaccine against COVID-19, post-vaccination-related acute myocarditis has PRESENTATION The a 16-year-old male case with no past relevant medical history. The patient had full immunization against SARS-CoV-2 with the BNT162B2 (Pfizer-BioNTech) vaccine; the second echocardiogram was performed with global and was prescribed. The patient was admitted our institution on July 10, 2021, with an improvement in symptoms. On emergency signs were normal. An electrocardiogram (ECG) showed sinus rhythm, 81 bpm, normal QRS and elevation of ST-segment (Figure 1). Chest-X /mL, internship. M\u00e9rida, Yucat\u00e1n, M\u00e9xico. gadobutrol (Gadovist \u00ae) (0.1 mmol / kg) was global hypokinesis of LV with administration of gadolinium, areas of the myocardium with early enhancement were identified in the level was anti-Salmonella typhi and paratyphi, Brucella and Proteus). Due to the temporal relationship between vaccination and the development of signs and symptoms having other etiologies, this be an adverse associated the BNT162b2 vaccine against COVID-19. Beta-blocker, antihypertensive and anti-inflammatory treatment was prescribed. Due to profile and favorable clinical evolution, endomyocardial biopsy was not considered. The without or pericarditis in the 12 and 29-year-old age group who received COVID-19 vaccines (November 4, 2021). Most cases in adolescents or young men after the second dose. The Centers for Disease Control and Prevention (CDC) Food and Drug Administration (FDA) confirmed 1,031 reports A B Figure 2: AngioCT with normal coronary hypodensity wall (D) with hypoperfusion demonstrated after the post-process (E and F) .121 L\u00f3pez-Mart\u00ednez SI et al. Acute myocarditis after BNT162b2 cases per 100,000 persons. 7-9,13 The Pfizer-BioNTech vaccine has been shown to be 94% to 95% effective in preventing COVID-19 in the to 55-year-old population and 100% effective in the 12-to-15-year age group. To date, the FDA has authorized its emergent use in the population aged 5 to 15 years and full approval in 16 years and older. The long-term risks unknown. The adverse reactions in different vaccines within the Q waves, AV branch block, limited of and LGE. A positive case is defined as the presence of T2 be assessed non-invasively by using CMR-modified Lake Louise criteria. related myocarditis is a rare adverse event most likely seen in children, adolescents and young The CMR short axis showed lateral-apical, and anterior-apical segments (A). enhancement (B) is compatible with hyperemia. Non-ischemic pattern late enhancement in lateral subepicardial and B CL\u00f3pez-Mart\u00ednez that future research needed to provide more evidence that can establish recommendations based the of Hospital Alta REFERENCES 1. Richardson P , McK enna W, Bristow M, Maisch B, Mautner B, O'Connell J et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Barda N, Hoss S, Richter I, Wiessman M, Aviv Y et al. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med. 2021 Dec 2; 385 (23): 2132-2139. 8. Dionne A, Sperotto F , Chamberlain S, Baker AL, Powell AJ, Prakash A et al. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021; E1-5. 9. Albert E, Aurigemma 10. A, Sitges M, Prat-Gonzalez S. Diagn\u00f3stico de la miocarditis. Papel de las t\u00e9cnicas de imagen. Cardiocore. 2012 Oct; 47 (4): Carbone Myocarditis: Radiol 125 1124-1134. 12. Luetkens A, Isaak Dabir D, Kuetting D, Feisst A, et al. Comparison of Original and 2018 Lake Louise Criteria for J Med. 2021 Dec 2; 385 (23): 2189-90. 15. Marshall M, Ferguson ID, Lewis P , Jaggi P , Gagliardo C, (3): 2021. Available: 17. Bautista Garc\u00eda J, Pe\u00f1a Ortega P , Bonilla Fern\u00e1ndez JA, C\u00e1rdenes Le\u00f3n A, Ram\u00edrez Burgos L, Caballero Dorta E. Miocarditis aguda tras administraci\u00f3n de vacuna BNT162b2 contra la COVID-19. Rev Esp Cardiol. 2021 Sep 1; 74 (9): 812-814. Holmvang G, Alakija P , Cooper et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Eur Heart Funding/support: received for this study.Conflict of interest: the authors "}